These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33892061)

  • 1. Curcumin-loaded liposomes with the hepatic and lysosomal dual-targeted effects for therapy of hepatocellular carcinoma.
    Wang Y; Ding R; Zhang Z; Zhong C; Wang J; Wang M
    Int J Pharm; 2021 Jun; 602():120628. PubMed ID: 33892061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and Synthesis of Galactose-Biotin Lipid Materials for Liposomes to Promote the Hepatoma Cell-Targeting Effect.
    Ding R; Li Z; Wang J; Zhu X; Zhao Z; Wang M
    J Pharm Sci; 2019 Sep; 108(9):3074-3081. PubMed ID: 30981753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological evaluation of novel dual-targeting fluorescent probes for detection of Fe
    Wang Y; Liu F; Yi Q; Wang M; Wang J
    Talanta; 2022 Jun; 243():123362. PubMed ID: 35276499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-Delivery of Curcumin and Capsaicin by Dual-Targeting Liposomes for Inhibition of aHSC-Induced Drug Resistance and Metastasis.
    Qi C; Wang D; Gong X; Zhou Q; Yue X; Li C; Li Z; Tian G; Zhang B; Wang Q; Wei X; Wu J
    ACS Appl Mater Interfaces; 2021 Apr; 13(14):16019-16035. PubMed ID: 33819006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galactose-imidazole mediated dual-targeting fluorescent probe for detecting Fe
    Wang Y; Liu F; Pu C; Tong Z; Wang M; Wang J
    Biosens Bioelectron; 2022 May; 204():114083. PubMed ID: 35176648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galactose Modified Liposomes for Effective Co-Delivery of Doxorubicin and Combretastatin A4.
    Lian B; Wei H; Pan R; Sun J; Zhang B; Wu J; Li X; Tian G
    Int J Nanomedicine; 2021; 16():457-467. PubMed ID: 33488080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-Ligand-Modified Liposomes Co-Loaded with Anti-Angiogenic and Chemotherapeutic Drugs for Inhibiting Tumor Angiogenesis and Metastasis.
    Wang F; Li Y; Jiang H; Li C; Li Z; Qi C; Li Z; Gao Z; Zhang B; Wu J
    Int J Nanomedicine; 2021; 16():4001-4016. PubMed ID: 34135585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro and In Vivo Evaluation of SP94 Modified Liposomes Loaded with N-14NCTDA, a Norcantharimide Derivative for Hepatocellular Carcinoma-Targeting.
    Jiang Y; Liu X; Tan X; Hou Y; Sun W; Gou J; Yin T; He H; Zhang Y; Tang X
    AAPS PharmSciTech; 2020 Oct; 21(7):277. PubMed ID: 33033942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asialoglycoprotein receptor-targeted liposomes loaded with a norcantharimide derivative for hepatocyte-selective targeting.
    Liu X; Han M; Xu J; Geng S; Zhang Y; Ye X; Gou J; Yin T; He H; Tang X
    Int J Pharm; 2017 Mar; 520(1-2):98-110. PubMed ID: 28167263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma.
    Cheng Y; Zhao P; Wu S; Yang T; Chen Y; Zhang X; He C; Zheng C; Li K; Ma X; Xiang G
    Int J Pharm; 2018 Jul; 545(1-2):261-273. PubMed ID: 29730175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carrier-free self-assembled nanomedicine based on celastrol and galactose for targeting therapy of hepatocellular carcinoma via inducing ferroptosis.
    Zhang X; Chen Y; Li X; Xu H; Yang J; Wang C; Zhang C; Deng Y; Lu A; Zheng C; Lu J
    Eur J Med Chem; 2024 Mar; 267():116183. PubMed ID: 38354520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Octanoyl galactose ester-modified microemulsion system self-assembled by coix seed components to enhance tumor targeting and hepatoma therapy.
    Qu D; Liu M; Huang M; Wang L; Chen Y; Liu C; Liu Y
    Int J Nanomedicine; 2017; 12():2045-2059. PubMed ID: 28352174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transporter occluded-state conformation-induced endocytosis: Amino acid transporter ATB
    Luo Q; Gong P; Sun M; Kou L; Ganapathy V; Jing Y; He Z; Sun J
    J Control Release; 2016 Dec; 243():370-380. PubMed ID: 27810556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folate receptor-targeted liposomes loaded with a diacid metabolite of norcantharidin enhance antitumor potency for H22 hepatocellular carcinoma both in vitro and in vivo.
    Liu MC; Liu L; Wang XR; Shuai WP; Hu Y; Han M; Gao JQ
    Int J Nanomedicine; 2016; 11():1395-412. PubMed ID: 27110110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of novel butyryl galactose ester-modified coix component microemulsions and evaluation on hepatoma-targeting in vitro and in vivo.
    Liu MJ; Qu D; Chen Y; Liu CY; Liu YP; Ding XF
    Drug Deliv; 2016 Nov; 23(9):3444-3451. PubMed ID: 27198659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of 11-DGA-3-
    Zhou L; Zou M; Zhu K; Ning S; Xia X
    Molecules; 2019 Aug; 24(17):. PubMed ID: 31450608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomes for targeting hepatocellular carcinoma: use of conjugated arabinogalactan as targeting ligand.
    Shah SM; Goel PN; Jain AS; Pathak PO; Padhye SG; Govindarajan S; Ghosh SS; Chaudhari PR; Gude RP; Gopal V; Nagarsenker MS
    Int J Pharm; 2014 Dec; 477(1-2):128-39. PubMed ID: 25311181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galactose-Modified PH-Sensitive Niosomes for Controlled Release and Hepatocellular Carcinoma Target Delivery of Tanshinone IIA.
    Hu X; Zhang J; Deng L; Hu H; Hu J; Zheng G
    AAPS PharmSciTech; 2021 Mar; 22(3):96. PubMed ID: 33694067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GA&HA-Modified Liposomes for Co-Delivery of Aprepitant and Curcumin to Inhibit Drug-Resistance and Metastasis of Hepatocellular Carcinoma.
    Li Y; Wu J; Lu Q; Liu X; Wen J; Qi X; Liu J; Lian B; Zhang B; Sun H; Tian G
    Int J Nanomedicine; 2022; 17():2559-2575. PubMed ID: 35698562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel PEG-matrix metalloproteinase-2 cleavable peptide-lipid containing galactosylated liposomes for hepatocellular carcinoma-selective targeting.
    Terada T; Iwai M; Kawakami S; Yamashita F; Hashida M
    J Control Release; 2006 Apr; 111(3):333-42. PubMed ID: 16488046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.